R&D Systems™ Recombinant Human IL-23 Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems™ 1290IL500/CF
DescriptionThe Recombinant Human IL-23 Protein is derived from Sf 21 (baculovirus). The Recombinant Human IL-23 Protein has been validated for the following applications: Bioactivity.
|P29460 (p40) and AAG37232(p19)|
|>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-23 protein, (N-terminus) Human IL-23 p40 (Ile23-Ser328) Accession &Num; P29460 GSGSSRGGSGSGGSGGGGSKL Human IL-23 p19 (Arg20-Pro189) Accession &Num; AAG37232 (C-terminus)|
|<1.0EU per 1μg of the protein by the LAL method.|
|Supplied as a 0.2μm filtered solution in MES, NaCl and EDTA.|
|55.0kDa (IL-23 single chain), 36.5kDa (p40), 18.5kDa (p19)|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, -20 to -70° C under sterile conditions after opening.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok